(VIANEWS) – ODFJELL DRILLING (ODL.OL), ALTRI SGPS (ALTR.LS), VÅR ENERGI (VAR.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ODFJELL DRILLING (ODL.OL)
997.7% sales growth and 18.26% return on equity
Odfjell Drilling Ltd. owns and operates mobile offshore drilling units primarily in Norway and Namibia. The company operates through Own Fleet and External Fleet segments. It also offers management services to other owners of drilling units, such as operational management, regulatory requirements management, marketing, contract negotiations and client relations, and operation and mobilization preparation services. The company was founded in 1914 and is headquartered in Aberdeen, the United Kingdom. Odfjell Drilling Ltd. is a subsidiary of Odfjell Partners Holding Ltd.
Earnings Per Share
As for profitability, ODFJELL DRILLING has a trailing twelve months EPS of kr10.8.
PE Ratio
ODFJELL DRILLING has a trailing twelve months price to earnings ratio of 4.86. Meaning, the purchaser of the share is investing kr4.86 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.26%.
Volume
Today’s last reported volume for ODFJELL DRILLING is 133880 which is 81.55% below its average volume of 725952.
More news about ODFJELL DRILLING.
2. ALTRI SGPS (ALTR.LS)
39.3% sales growth and 18.52% return on equity
Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.37.
PE Ratio
ALTRI SGPS has a trailing twelve months price to earnings ratio of 13.97. Meaning, the purchaser of the share is investing €13.97 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.52%.
Yearly Top and Bottom Value
ALTRI SGPS’s stock is valued at €5.17 at 02:20 EST, below its 52-week high of €5.63 and way above its 52-week low of €4.21.
More news about ALTRI SGPS.
3. VÅR ENERGI (VAR.OL)
34.3% sales growth and 50.7% return on equity
Vår Energi AS operates as an independent upstream oil and gas company on the Norwegian continental shelf in Norway. It produces crude oil, liquified natural gas, and natural gas liquids. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was incorporated in 1965 and is headquartered in Sandnes, Norway. Vår Energi AS operates as a subsidiary of Eni International B.V.
Earnings Per Share
As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr2.7.
PE Ratio
VÅR ENERGI has a trailing twelve months price to earnings ratio of 13.23. Meaning, the purchaser of the share is investing kr13.23 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.7%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 29, 2024, the estimated forward annual dividend rate is 4.74 and the estimated forward annual dividend yield is 14.62%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 20.7% and 138.9%, respectively.
Moving Average
VÅR ENERGI’s value is above its 50-day moving average of kr34.44 and higher than its 200-day moving average of kr34.22.
More news about VÅR ENERGI.
4. AKER SOLUTIONS (AKSO.OL)
16.8% sales growth and 17.09% return on equity
Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry in Norway, the United States, Brazil, the United Kingdom, Malaysia, Angola, Brunei, Canada, India, and internationally. The company operates in two segments, Renewables and Field Development; and Life Cycle. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of oil and gas production, and receiving and processing facilities. The company also provides offshore fish farming, carbon capture, utilization and storage, hydrogen and derivatives, hydropower, and offshore wind solutions. Further, it designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.06.
PE Ratio
AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 13.67. Meaning, the purchaser of the share is investing kr13.67 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.
Yearly Top and Bottom Value
AKER SOLUTIONS’s stock is valued at kr41.84 at 02:20 EST, way below its 52-week high of kr50.00 and way higher than its 52-week low of kr33.14.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 48.05B for the twelve trailing months.
More news about AKER SOLUTIONS.
5. J.MARTINS,SGPS (JMT.LS)
9.7% sales growth and 23.95% return on equity
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal, and under the Bodega del Canasto name in Colombia. In addition, it operates restaurants under the Pingo Doce name; para-pharmacies and petrol stations under Bem-Estar brand; and clothing under Code brand. Further, the company operates coffee shops and kiosks under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; rental of air transport equipment; and provision of business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. operates as a subsidiary of Sociedade Francisco Manuel Dos Santos, S.G.P.S., S.A.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.04.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 16.72. Meaning, the purchaser of the share is investing €16.72 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.95%.
Yearly Top and Bottom Value
J.MARTINS,SGPS’s stock is valued at €17.39 at 02:20 EST, way under its 52-week high of €24.02 and way higher than its 52-week low of €15.20.
Moving Average
J.MARTINS,SGPS’s worth is higher than its 50-day moving average of €16.70 and way below its 200-day moving average of €19.35.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 22.2% and positive 3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 32.39B for the twelve trailing months.
More news about J.MARTINS,SGPS.
6. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 47.08B for the twelve trailing months.
Moving Average
SANOFI’s worth is below its 50-day moving average of €100.56 and under its 200-day moving average of €92.72.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 5.2% and positive 0.8% for the next.
More news about SANOFI.
7. SKUE SPAREBANK (SKUE.OL)
6% sales growth and 9.61% return on equity
Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, consumer, car, other vehicle, and small loans, as well as mortgage, bank guarantee, factoring, overdraft, and leasing services; and home and leisure, car and other vehicles, animal, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.
Earnings Per Share
As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr102.59.
PE Ratio
SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.42. Meaning, the purchaser of the share is investing kr2.42 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.61%.
Yearly Top and Bottom Value
SKUE SPAREBANK’s stock is valued at kr248.50 at 02:20 EST, under its 52-week high of kr250.00 and way above its 52-week low of kr214.00.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 11.3% and positive 0.3% for the next.
More news about SKUE SPAREBANK.
8. IMCD (IMCD.AS)
5.4% sales growth and 16.47% return on equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives. It offers actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, film formers, humectants, waxes, conditioners, hair styling polymers, solvent, solubilizers, pigments, pearls, powders and colorants, opacifiers, pearlizers, preservatives, antioxidants, fragrances, and essential oils. In addition, the company provides functional fillers, pigments, resins, and specialty solvents; taste, texture, nutrition, and function; and abrasives, acids, alkalines, anti-soil redeposition and foam control systems, bio-actives, biocides, bittering and bleaching agents, builders, capsules, chelating agents, concentrates/ready-to-use, corrosion and dye transfer inhibitors, disintegrants, dispersants, emulsifiers, enzymes, fluorinated polymers, oleo chemicals, optical brighteners, perfumes, dyes, phosphates, plasticisers, proteins, rheology modifiers and thickeners, silicones, solvents/diluents, TAED, UV-filters, and waxes. Further, it offers base oils; lubricants addictive; lubricants finished fluids; fuel additives; solvents, degreasers, and fuel compounds; and upstream, midstream, and downstream oil, gas, and energy. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €4.94.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 30.83. Meaning, the purchaser of the share is investing €30.83 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.47%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 16, 2024, the estimated forward annual dividend rate is 2.24 and the estimated forward annual dividend yield is 1.47%.
Moving Average
IMCD’s value is above its 50-day moving average of €146.23 and higher than its 200-day moving average of €145.20.
Yearly Top and Bottom Value
IMCD’s stock is valued at €152.30 at 02:20 EST, below its 52-week high of €169.05 and way higher than its 52-week low of €109.05.
More news about IMCD.
